Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
101 USD | -0.06% | +3.62% | +12.48% |
May. 09 | Earnings Flash (KODK) EASTMAN KODAK Reports Q1 Revenue $249M | MT |
May. 06 | Barclays Adjusts Price Target on Eastman Chemical to $103 From $85, Maintains Equalweight Rating | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company is in debt and has limited leeway for investment
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.48% | 11.88B | A- | ||
-1.96% | 74.28B | B | ||
+0.05% | 46.91B | A- | ||
+2.38% | 32.93B | C | ||
+7.54% | 17.78B | B | ||
-6.58% | 12.09B | B | ||
-0.23% | 10.66B | - | ||
+3.37% | 9.55B | A- | ||
+5.01% | 8.28B | B | ||
-8.19% | 8.08B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- EMN Stock
- Ratings Eastman Chemical Company